Doxorubicin (DOX) is associated with numerous acute and chronic dose-related toxicities
including hepatotoxicity. This adverse reaction may limit the use of other chemotherapeutic …

Although doxorubicin (DOX) is a commonly used chemotherapeutic agent its clinical use is
restricted due to its organ toxicities. The present investigation relates to reducing DOX …

The present study was conducted to evaluate the protective role of rutin and hesperidin on
experimental doxorubicin induced hepatotoxicity. Doxorubicin (DXR) administered rats (25 …

Alpha-lipoic acid (α-LA) is not only involved in energy metabolism, but is also a powerful
antioxidant that can protect against hepatic oxidative stress induced by some drugs, toxins …

Background At a glance commentary Scientific background on the subject Since Adriamycin
is used as an anticancer drug among various communities and is one of its side-effects, it is …

Objective To observe the combination effect of doxorubicin and Citrus hystrix (kaffir lime's)
peel ethanolic extract (ChEE) on blood serum alanine aminotransferase (ALT) and aspartate …

Objective: To evaluate the effect of p-coumaric acid against adriamycin-induced
hepatotoxicity in rats. Methods: The rats were divided into 4 groups. The control group …

Cancer is one of the most common human diseases and a leading cause of human mortality
in rencent years. Doxorubicin (DOX) is an important anti-cancer agent belonging to …

Objective—To evaluate the toxicity and efficacy of a modification of a previously evaluated
combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue …

Background Doxorubicin (DOX) is a common chemotherapeutic drug. However, it causes
cardiomyopathy which reduces its clinical use in human cancer therapy. Objective The …